Polynovo Ltd
ASX:PNV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Yincheng Life Service Co Ltd
HKEX:1922
|
CN |
|
All for One Group SE
XETRA:A1OS
|
DE |
|
Iochpe Maxion SA
BOVESPA:MYPK3
|
BR |
|
G
|
Guangdong Biolight Meditech Co Ltd
SZSE:300246
|
CN |
Polynovo Ltd
Total Equity
Polynovo Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Polynovo Ltd
ASX:PNV
|
Total Equity
AU$83.1m
|
CAGR 3-Years
10%
|
CAGR 5-Years
30%
|
CAGR 10-Years
19%
|
|
|
Nanosonics Ltd
ASX:NAN
|
Total Equity
AU$219.7m
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
18%
|
|
|
SDI Ltd
ASX:SDI
|
Total Equity
AU$103.4m
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
|
Anteris Technologies Ltd
ASX:AVR
|
Total Equity
-AU$90k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ansell Ltd
ASX:ANN
|
Total Equity
$2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
|
L
|
Lumos Diagnostics Holdings Ltd
ASX:LDX
|
Total Equity
$6.2m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
Polynovo Ltd
Glance View
Polynovo Ltd. engages in the provision biodegradable medical devices. The company is headquartered in Melbourne, Victoria and currently employs 122 full-time employees. The Company’s principal activity is the development of medical devices for various applications. The Company’s products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb technology. BTM is a man-made synthetic polymer that does not contain any biologic materials. BTM is a skin treatment. NovoSorb is a polymer, which is utilizes for the manufacture of novel medical devices, such as Biocompatible polymers. These biocompatible polymers are designed to support different functions of the body and then biodegrade into by-products that can be absorbed and excreted by the body. The company can be produced in a range of formats with different mechanical and degradation properties. In addition to NovoSorb BTM, they can be used for thermoplastic extrusions, filaments for weaving or knitting and as a solution for spray or dip coatings of other devices.
See Also
What is Polynovo Ltd's Total Equity?
Total Equity
83.1m
AUD
Based on the financial report for Dec 31, 2025, Polynovo Ltd's Total Equity amounts to 83.1m AUD.
What is Polynovo Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
19%
Over the last year, the Total Equity growth was 10%. The average annual Total Equity growth rates for Polynovo Ltd have been 10% over the past three years , 30% over the past five years , and 19% over the past ten years .
